Integrated Project funded by the
European Community,
Framework Programme 6

coordinated by the
for Molecular Medicine (MDC)

Here you can find the latest positions available within EuReGene. Candidates are encouraged to contact the institute of their interest directly, even if no open positions are listed here. New job opportunities will be added here as they come available. Check this site regularly for new openings.

Group Leaders in Molecular Medicine: Institute for Molecular Medicine Finland (FIMM) - posted April 2008

Tenure Track/Tenured Position, Basic Biomedical Research: Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, Division of Intramural Research, Bethesda, MD, USA - posted February 2008

Group Leaders in Molecular Medicine, Institute for Molecular Medicine Finland (FIMM), Finland

The Institute for Molecular Medicine Finland (FIMM, ) was established in 2007 as a partner institution of the European Molecular Biology Laboratory ( together with the new Nordic nodes for molecular medicine in Norway and Sweden. FIMM was inaugurated as a joint venture of the University of Helsinki, the Hospital District of Helsinki and Uusimaa (HUS), the National Public Health Institute (KTL) with VTT Technical Research Centre of Finland joining in 2008. FIMM headquarters are located in a brand new state-of-the art Biomedicum Helsinki 2 research building on the Meilahti medical campus in Helsinki.

The research areas of FIMM include: 1) Genetic epidemiology and genomics of cardiovascular and neuropsychiatric diseases and cancer 2) Medical systems biology and medical bioinformatics of common diseases, with a focus on cancer, diabetes and obesity 3) Leveraging the aforementioned research for translational applications, including health impact of genes, new diagnostic methods, biomarkers and therapeutics. FIMM also develops infrastructures for biobanking, medical bioinformatics, high-throughput sequencing, high-throughput screening, and other translational research platforms, including participation in the EU�s ESFRI programs BBMRI and EATRIS.

FIMM is seeking outstanding international candidates for the prestigious positions of Group leaders in Molecular Medicine

Group leaders are expected to relocate to Finland and initiate a new research program as part of the new Nordic EMBL Partnership for Molecular Medicine. The group leaders are nominated for a 5-year term, which is renewable for up to four additional years. We expect to hire 3 � 4 new principal investigators from this call.

FIMM provides attractive sustainable support packages for new international group leaders of up to 1,2 � 1,7 M euro for the fi ve year period. This includes salaries of the group leader, 1 � 2 postdoctoral fellows, 2 � 3 doctoral students and technician(s), consumables and modern laboratory facilities. The candidates are expected to complement this budget through other national or international grants and/or through industrial collaborations. FIMM scientists will be supported by unique research infrastructures for high-throughput research developed at FIMM and enjoy access to the local research community�s infrastructures (,, national infrastructures ( and international capabilities provided by EMBL. Assistance and fi nancial support is also provided for international relocation.

Qualification requirements include a MD/PhD, PhD or equivalent degree, appropriate postdoctoral training and a track-record of high-impact publications in the top journals for biology or medicine. Group leader positions are intended for early-stage independent investigators, comparable with the assistant or associate professor level, with the latter group expected to show a track record for attracting significant independent funding.

Successful candidates are expected to initiate a new independent research program with a clear relevance to molecular medicine with signifi cant translational opportunities. We expect multi-disciplinary research collaborations with other FIMM research groups, with the internationally recognized biomedical and medical research environment in Helsinki, as well as with other top Finnish scientists, including the Centres of Excellence of the Academy of Finland ( We hope thecandidates will be able to make use of the FIMM technology platforms in their research or to contribute towards technology development.

Applications should include a covering letter summarizing the applicant�s career and future plans (1 page), CV and a list of publications (past 10 years only, with 5 most significant publications indicated), short research plan (max 3 pages) with a summary of expected translational, medical or public health impact, and names of three references.

Applications should be addressed to the Board of FIMM and sent electronically to the Institute for Molecular Medicine Finland (FIMM) at fi to arrive no later than 8 April 2008.

The top candidates are invited to visit Helsinki in May for a lecture and discussions, and to provide a more detailed research plan as well as letters of reference. An international panel will evaluate the candidates and the proposals. The fi rst candidates may be nominated in June with an anticipated starting date in the fall of 2008, or at the latest by the end of the year.

For further information please contact Director, Professor Olli Kallioniemi (olli.kallioniemi AT or visit our website for details of the call for group leaders.

Download Advertisment
Download Call for Propsals Form


Tenure Track/Tenured Position, Basic Biomedical Research, Bethesda, MD, USA

Division of Intramural Research (DIR) of the National Heart, Lung and Blood Institute is seeking an outstanding scientist to initiate and direct an independent research program on the NIH campus in Bethesda, MD. The area of expertise of the candidate is less important than his/her demonstrated ability to conduct outstanding independent research in areas within the broad interests of the DIR. The areas of expertise may include but are not limited to: molecular and cellular biology, biophysics, biochemistry, immunology, systems biology, physiology, signal transduction, developmental biology, and molecular imaging. Potential candidates are welcome to view the NHLBI DIR web pages ( to review the research programs and support available within the DIR. The existing faculty is an outstanding group of internationally recognized biomedical researchers covering a wide range of basic and clinical research topics complemented by the other DIR programs within NIH. Strong research core support in optical and electron microscopy, transgenic and knockout mouse production, mouse phenotyping, proteomics, genomics, and flow cytometry/cell sorting is available to the DIR faculty. Candidates can also participate in Graduate Partners Programs ( with many academic programs around the world as a means of recruiting graduate students.

The candidate must have an M.D., Ph.D., or both and have an outstanding record of research accomplishments as evidenced by publications in major peer-reviewed journals. The position can be filled as a tenure-track or tenured position, but preference will be given to senior post-doctoral fellows or faculty who are still in the early stages of their research careers. The successful candidate will be offered a competitive salary commensurate with experience and qualifications, and will be assigned ample research space, supported positions, and an operating budget. Appointees may be US citizens, resident aliens, or non-resident aliens with or eligible to obtain a valid employment authorized visa. Applications must be received by February 1, 2008. Please submit a curriculum vitae and brief statement of research interests along with three letters of reference to:

Robert S. Balaban, Ph.D., Scientific Director, NHLBI c/o Mary McMahon Administrative Officer, NHLBI 10 Center Drive, MSC 1670 Building 10, Room 7N220 Bethesda, MD 20892-1670

DHHS and NIH are Equal Opportunity Employers. Applications from women, minorities and persons with disabilities are strongly encouraged.

  last update 23.04.2008, by Chris Tindal